VEGFA activates an epigenetic pathway upregulating ovarian cancer-initiating cells

Kibeom Jang, Minsoon Kim, Candace A. Gilbert, Fiona Simpkins, Tan Ince, Joyce M Slingerland

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The angiogenic factor, VEGFA, is a therapeutic target in ovarian cancer (OVCA). VEGFA can also stimulate stem-like cells in certain cancers, but mechanisms thereof are poorly understood. Here, we show that VEGFA mediates stem cell actions in primary human OVCA culture and OVCA lines via VEGFR2-dependent Src activation to upregulate Bmi1, tumor spheres, and ALDH1 activity. The VEGFA-mediated increase in spheres was abrogated by Src inhibition or SRC knockdown. VEGFA stimulated sphere formation only in the ALDH1+ subpopulation and increased OVCA-initiating cells and tumor formation in vivo through Bmi1. In contrast to its action in hemopoietic malignancies, DNA methyl transferase 3A (DNMT3A) appears to play a pro-oncogenic role in ovarian cancer. VEGFA-driven Src increased DNMT3A leading to miR-128-2 methylation and upregulation of Bmi1 to increase stem-like cells. SRC knockdown was rescued by antagomir to miR-128. DNMT3A knockdown prevented VEGFA-driven miR-128-2 loss, and the increase in Bmi1 and tumor spheres. Analysis of over 1,300 primary human OVCAs revealed an aggressive subset in which high VEGFA is associated with miR-128-2 loss. Thus, VEGFA stimulates OVCA stem-like cells through Src-DNMT3A-driven miR-128-2 methylation and Bmi1 upregulation.

Original languageEnglish (US)
Pages (from-to)304-318
Number of pages15
JournalEMBO Molecular Medicine
Volume9
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Epigenomics
Ovarian Neoplasms
Transferases
Up-Regulation
Stem Cells
Neoplastic Stem Cells
DNA
Methylation
Neoplasms
Angiogenesis Inducing Agents

Keywords

  • Bmi1
  • cancer stem-like cell
  • epigenetic
  • miR-128
  • VEGFA

ASJC Scopus subject areas

  • Molecular Medicine

Cite this

VEGFA activates an epigenetic pathway upregulating ovarian cancer-initiating cells. / Jang, Kibeom; Kim, Minsoon; Gilbert, Candace A.; Simpkins, Fiona; Ince, Tan; Slingerland, Joyce M.

In: EMBO Molecular Medicine, Vol. 9, No. 3, 01.03.2017, p. 304-318.

Research output: Contribution to journalArticle

Jang, Kibeom ; Kim, Minsoon ; Gilbert, Candace A. ; Simpkins, Fiona ; Ince, Tan ; Slingerland, Joyce M. / VEGFA activates an epigenetic pathway upregulating ovarian cancer-initiating cells. In: EMBO Molecular Medicine. 2017 ; Vol. 9, No. 3. pp. 304-318.
@article{0a928490cc36469c80965df945a7f77d,
title = "VEGFA activates an epigenetic pathway upregulating ovarian cancer-initiating cells",
abstract = "The angiogenic factor, VEGFA, is a therapeutic target in ovarian cancer (OVCA). VEGFA can also stimulate stem-like cells in certain cancers, but mechanisms thereof are poorly understood. Here, we show that VEGFA mediates stem cell actions in primary human OVCA culture and OVCA lines via VEGFR2-dependent Src activation to upregulate Bmi1, tumor spheres, and ALDH1 activity. The VEGFA-mediated increase in spheres was abrogated by Src inhibition or SRC knockdown. VEGFA stimulated sphere formation only in the ALDH1+ subpopulation and increased OVCA-initiating cells and tumor formation in vivo through Bmi1. In contrast to its action in hemopoietic malignancies, DNA methyl transferase 3A (DNMT3A) appears to play a pro-oncogenic role in ovarian cancer. VEGFA-driven Src increased DNMT3A leading to miR-128-2 methylation and upregulation of Bmi1 to increase stem-like cells. SRC knockdown was rescued by antagomir to miR-128. DNMT3A knockdown prevented VEGFA-driven miR-128-2 loss, and the increase in Bmi1 and tumor spheres. Analysis of over 1,300 primary human OVCAs revealed an aggressive subset in which high VEGFA is associated with miR-128-2 loss. Thus, VEGFA stimulates OVCA stem-like cells through Src-DNMT3A-driven miR-128-2 methylation and Bmi1 upregulation.",
keywords = "Bmi1, cancer stem-like cell, epigenetic, miR-128, VEGFA",
author = "Kibeom Jang and Minsoon Kim and Gilbert, {Candace A.} and Fiona Simpkins and Tan Ince and Slingerland, {Joyce M}",
year = "2017",
month = "3",
day = "1",
doi = "10.15252/emmm.201606840",
language = "English (US)",
volume = "9",
pages = "304--318",
journal = "EMBO Molecular Medicine",
issn = "1757-4676",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - VEGFA activates an epigenetic pathway upregulating ovarian cancer-initiating cells

AU - Jang, Kibeom

AU - Kim, Minsoon

AU - Gilbert, Candace A.

AU - Simpkins, Fiona

AU - Ince, Tan

AU - Slingerland, Joyce M

PY - 2017/3/1

Y1 - 2017/3/1

N2 - The angiogenic factor, VEGFA, is a therapeutic target in ovarian cancer (OVCA). VEGFA can also stimulate stem-like cells in certain cancers, but mechanisms thereof are poorly understood. Here, we show that VEGFA mediates stem cell actions in primary human OVCA culture and OVCA lines via VEGFR2-dependent Src activation to upregulate Bmi1, tumor spheres, and ALDH1 activity. The VEGFA-mediated increase in spheres was abrogated by Src inhibition or SRC knockdown. VEGFA stimulated sphere formation only in the ALDH1+ subpopulation and increased OVCA-initiating cells and tumor formation in vivo through Bmi1. In contrast to its action in hemopoietic malignancies, DNA methyl transferase 3A (DNMT3A) appears to play a pro-oncogenic role in ovarian cancer. VEGFA-driven Src increased DNMT3A leading to miR-128-2 methylation and upregulation of Bmi1 to increase stem-like cells. SRC knockdown was rescued by antagomir to miR-128. DNMT3A knockdown prevented VEGFA-driven miR-128-2 loss, and the increase in Bmi1 and tumor spheres. Analysis of over 1,300 primary human OVCAs revealed an aggressive subset in which high VEGFA is associated with miR-128-2 loss. Thus, VEGFA stimulates OVCA stem-like cells through Src-DNMT3A-driven miR-128-2 methylation and Bmi1 upregulation.

AB - The angiogenic factor, VEGFA, is a therapeutic target in ovarian cancer (OVCA). VEGFA can also stimulate stem-like cells in certain cancers, but mechanisms thereof are poorly understood. Here, we show that VEGFA mediates stem cell actions in primary human OVCA culture and OVCA lines via VEGFR2-dependent Src activation to upregulate Bmi1, tumor spheres, and ALDH1 activity. The VEGFA-mediated increase in spheres was abrogated by Src inhibition or SRC knockdown. VEGFA stimulated sphere formation only in the ALDH1+ subpopulation and increased OVCA-initiating cells and tumor formation in vivo through Bmi1. In contrast to its action in hemopoietic malignancies, DNA methyl transferase 3A (DNMT3A) appears to play a pro-oncogenic role in ovarian cancer. VEGFA-driven Src increased DNMT3A leading to miR-128-2 methylation and upregulation of Bmi1 to increase stem-like cells. SRC knockdown was rescued by antagomir to miR-128. DNMT3A knockdown prevented VEGFA-driven miR-128-2 loss, and the increase in Bmi1 and tumor spheres. Analysis of over 1,300 primary human OVCAs revealed an aggressive subset in which high VEGFA is associated with miR-128-2 loss. Thus, VEGFA stimulates OVCA stem-like cells through Src-DNMT3A-driven miR-128-2 methylation and Bmi1 upregulation.

KW - Bmi1

KW - cancer stem-like cell

KW - epigenetic

KW - miR-128

KW - VEGFA

UR - http://www.scopus.com/inward/record.url?scp=85012273643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012273643&partnerID=8YFLogxK

U2 - 10.15252/emmm.201606840

DO - 10.15252/emmm.201606840

M3 - Article

C2 - 28179359

AN - SCOPUS:85012273643

VL - 9

SP - 304

EP - 318

JO - EMBO Molecular Medicine

JF - EMBO Molecular Medicine

SN - 1757-4676

IS - 3

ER -